300482 萬孚生物
按盤價 
17.950 +0.030 (+0.167%)
17.950 +0.030 (+0.167%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.544 | -1.149 | 11.154 | 11.007 | 31.105 |
| 總資產報酬率 ROA (%) | 1.266 | -0.916 | 8.690 | 8.078 | 21.458 |
| 投入資產回報率 ROIC (%) | 1.354 | -1.012 | 9.745 | 9.139 | 25.310 | 邊際利潤分析 |
| 銷售毛利率 (%) | 63.243 | 56.975 | 64.145 | 62.611 | 51.824 |
| 營業利潤率 (%) | 16.832 | -5.291 | 20.779 | 19.861 | 24.078 |
| 息稅前利潤/營業總收入 (%) | 19.867 | -3.498 | 20.611 | 19.326 | 24.009 |
| 淨利潤/營業總收入 (%) | 14.804 | -3.338 | 18.442 | 17.629 | 20.951 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 92.379 | 141.888 | 100.220 | 86.963 | 98.971 |
| 價值變動淨收益/利潤總額(%) | 10.172 | -46.582 | 5.010 | 8.488 | 5.319 |
| 營業外收支淨額/利潤總額(%) | -0.761 | 3.729 | -1.173 | -1.549 | -0.235 | 償債能力分析 |
| 流動比率 (X) | 3.223 | 3.178 | 4.609 | 6.677 | 2.936 |
| 速動比率 (X) | 2.967 | 2.908 | 4.171 | 5.952 | 2.586 |
| 資產負債率 (%) | 17.171 | 17.088 | 21.026 | 20.048 | 27.988 |
| 帶息債務/全部投入資本 (%) | 10.870 | 10.940 | 9.666 | 11.762 | 18.144 |
| 股東權益/帶息債務 (%) | 807.676 | 800.848 | 916.117 | 730.796 | 441.986 |
| 股東權益/負債合計 (%) | 477.120 | 479.970 | 369.218 | 390.286 | 246.313 |
| 利息保障倍數 (X) | 6.282 | -1.750 | 284.607 | -83.428 | -1,954.013 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 119.500 | 162.994 | 100.648 | 74.110 | 32.907 |
| 存貨周轉天數 (天) | 116.717 | 128.334 | 116.457 | 130.828 | 51.713 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 22/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
